CIPRAZAFONE
UNII 8RSD11181G

Substance Identification & Data

This profile provides standardized clinical and technical data for Ciprazafone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8RSD11181G.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 75616-03-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

8RSD11181G

CAS Registry Number

75616-03-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CIPRAZAFONE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C19H18Cl2N2O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

GUHPHHSNJRSHLJ-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C78000

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

193989

Unique identification number in the NCBI database of chemical substances.

INN ID

5451

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(CNC1CC1)(=O)N(c2c(cc(cc2)Cl)C(c3c(cccc3)Cl)=O)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ciprazafone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.